| INTRODUCTION
Oral cavity squamous cell carcinoma (OSCC) represents a heterogeneous group of head and neck cancers. OSCC is one of the leading causes of cancer-related deaths worldwide. [1] [2] [3] Tongue squamous cell carcinoma (TSCC) is the most common cancer diagnosed in the oral cavity, comprising 25%-40% of oral carcinomas, and along with the closely related cancer of the floor of the mouth (15%-20%) accounts for more than half of all oral carcinomas when excluding those affecting the lips. 4 ,5 TSCC has a high recurrence rate, and is significantly more aggressive than other forms of oral cancer, with a propensity for rapid local invasion and spread. 6, 7 Tumor stage represented by the tumor, node, and metastasis staging system (TNM) is routinely regarded as the strongest prognostic parameter for patients with TSCC. However, similarly staged patients with TSCC may present with markedly different prognoses, indicating that the TNM stage cannot completely explain the tumor behavior. The detection of TSCC at an early-stage (T1/T2N0M0) does not always lead to a good prognosis, as 20%-40% of patients show occult metastasis at the presentation. [7] [8] [9] In general, oral cancers that have clinically evident cervical lymph node metastasis are treated with tumor resection and modified radical neck dissection, whereas earlystage oral cancers (cT1/T2N0 cases) are treated with primary tumor resection alone. In our experience, however, some cases classified as cT1-2N0M0 have delayed neck metastasis (DNM) during the early period after tumor resection. The resection margin and pathological differentiation of tumors are unsatisfactory in many cases, with respect to predicting DNM and poor prognosis of patients. 10 Therefore, it is important to identify novel predictors of metastasis for the TSCC treatment. Many investigators have
proposed that detailed histopathological grading of the tumors with specific histopathological scoring systems may help clinicians in the individualization of the treatment and in prognostication of patients with OSCC. [10] [11] [12] [13] [14] Although some studies have found such systems useful for prognostication of TSCC, [15] [16] [17] most of the models are either too cumbersome for clinical diagnosis or have no prognostic significance, particularly for TSCC. [18] [19] [20] [21] Tumor budding, defined as the presence of small single-cancercell clusters of fewer than five cells at the tumor invasive front, 22, 23 has been reported to be an independent prognostic factor for several cancers such as lung, gastrointestinal, colorectal, pancreatic, and esophageal cancers. [24] [25] [26] [27] [28] There are few reports on the role of tumor budding in oral cancer. [29] [30] [31] [32] [33] Tumor budding represents two main features of a malignancy: loss of cell adhesion and active tumor invasion. [34] [35] [36] These features represent a more aggressive and malignant tumor potential. 37 As tumor budding is easily identified in hematoxylin and eosin (H&E) or in immunohistochemically stained sections, it may be useful to screen patients who are candidates for elective neck lymph node dissection or multimodal therapy for this phenomenon after the surgery. The depth of tumor invasion has also been described as an important prognostic parameter for OSCCs, and a depth of ≥ 4 mm was found to be associated with lymph node metastasis; lymph node metastasis is considered to be the most important marker for guiding therapy and for predicting prognosis in OSCC. 31, 38, 39 obtained from all the patients enrolled in the study.
| Histopathological analyses
The formalin-fixed and paraffin-embedded specimens or slices archived at each institution were used for pathological analyses.
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Paraffin specimens were sectioned to a thickness of 4 µm and stained with H&E. All specimens were assessed by more than two pathologists who were blinded to the clinical data.
The depth of invasion (DOI) was measured from the tumor surface to the deepest point of invasion. 29, 31 The cut-off point for DOI was set at 4 mm. 29, 31, 38, 45 Tumor budding is defined as the presence of a single-cancer-cell or small cluster of < 5 cancer cells at the invasive front. Tumor budding and the adjacent tissue were determined at the tumor invasion front. Most other parameters were determined by conventional methods.
| Statistical analyses
All analyses were performed using the StatFlex ver.6 software (Artech Co., Osaka, Japan). The DNM rates and overall survival (OS)
rates were calculated by the Kaplan-Meier method and compared using the log-rank test. Variables with significant differences detected in the univariate analysis were used as explanatory variables to extract independent factors related to DNM by the multivariate analysis. The multivariate analysis was performed using the Cox proportional hazards model. For all statistical analyses, P values of < 0.05 were considered significant. Figure 3 ) and the 5-year OS rate was 90.9%. The DNM rate was 12.6% in T1 and 28.7% in T2 cases, demonstrating a significant difference (P = 0.0001; Figure 4A , Table 2 ). The DNM rate according to DOI was significantly different between < 4 mm and ≥ 4 mm cases (P < 0.0001; Figure 4B , Table 2 ). The patients who had no buds/field had significantly different DNM rates at 10.4%, compared with DNM rates of 26.2% for patients who had intermediate grade (1-4 buds/ field) (P = 0.0012) and 47.2% for patients who had high grade (≥5 buds/field) (P < 0.0001) budding ( Figure 4C , Table 2 ). The DNM rates were not significantly different for the lymphocytes and fibrous tissue at the adjacent tissue at invasive front ( Figure 5A , B, Table 2 ). However, the DNM rates in the adjacent tissue at the invasive front were significantly different between cases with muscle tissue (31.6%) and those without muscle tissue (6.6%) (P < 0.0001; Figure 5C , Table 2 ). Furthermore, a significant difference was seen between cases with fat tissue (37.2%) and those without fat tissue (14.4%) (P < 0.0001; Figure 5D , Table 2 ).
Patients with venous invasion and lymphovascular invasion had To identify new predictors of DNM in patients with early-stage tongue cancer, we evaluated several novel parameters, in addition to TNM classification and conventional histopathological parameters.
As new candidate predictors, tumor budding and adjacent tissue at the invasive front were used because they can be evaluated using H&E staining alone; this analysis procedure is performed routinely, and thus saves time and is cost-effective.
The DOI has been reported as a major predictor of occult neck metastasis or DNM in early-stage tongue cancer. Many studies have demonstrated a marked increase in DNM when the DOI was more than 4 mm. 29, 31, 38, 39, 45 In this study, we observed that a DOI ≥ 4 mm was an independent predictor of DNM.
Tumor budding has been reported to be associated with poor prognosis and lymph node metastasis in several types of carcinomas. [24] [25] [26] [27] [28] In particular, in colorectal cancer, tumor budding is recognized as a prognostic factor by the WHO, and the International Tumor Budding Consensus Conference (ITBCC) achieved consensus on 10 statements regarding diagnosis and assessment. 52 In addition, as≥ 5 tumor buds/field has been reported to be associated with a poor prognosis, [29] [30] [31] [32] we classified patients according to the number histochemical staining of pan-cytokeratin has been recommended by a previous study. 30 However, according to the ITBCC's recommendations, "tumor budding is counted by H&E" and "tumor budding is assessed in one hotspot at the invasive front." In this study, this assessment method was adopted for evaluating TSCC. Neck metastasis was also reported to be predicted by evaluating tumor budding in biopsy specimens. 53 However, evaluation in biopsy specimens is not equivalent to the assessment at the tumor invasive front, and may not allow for accurate evaluation of other parameters.
Cancer metastasis requires cancer cell invasion into the stroma, cancer cell invasion/migration into the vessels, and cancer cell colonization/proliferation in the lymph nodes. 54 The initiation of invasion is known to be induced by the epithelial-mesenchymal transition (EMT). 55, 56 As a correlation between EMT and tumor budding has been reported, 32, 57, 58 tumor budding can be regarded as an early step in cancer metastasis. 59 Therefore, in patients exhibiting tumor budding, the risk of DNM may be high. In this study, many patients had no tumor budding. This may have been because the patients in this study had early-stage tongue cancer and this metastasis step had not yet occurred. The main limitation of this study is that H&E staining was the only investigative method used for the analysis of resected specimens. At most institutions, H&E staining of resected specimens is used to evaluate conventional parameters. Therefore, no additional efforts in cost and time were necessary for evaluating the parameters in this study. However, there is a possibility that tumor budding and adjacent tissues at the invasive front can be more accurately evaluated by immunostaining, which requires further studies. A detailed investigation about OS was not important in this study because cases with local recurrence were excluded and the follow-up period was short. In studies of patients with early-stage tongue cancer, a long follow-up period and the inclusion of local recurrence cases are necessary to investigate the correlation of OS with each parameter. Furthermore, in this study, the DOI was evaluated using resected specimens (surgical specimens), similar to previous studies. 29, 31, 38, 39, 45 Preoperative imaging-based DOI assessment was not included in the criteria for determining a therapeutic strategy and whether END should be performed. For patients who did not require reconstruction with a vascular pedicle free flap, the "wait and see" policy without END was the selected treatment method. Future studies should probably include DOI assessment with various preoperative imaging procedures to determine how significant a factor it is in predicting occult metastases. 
